Join
Live feed
·
INSIDERFilingvia Quantisnow
Theravance Biopharma Inc. logo

SVP, COMM & MEDICAL AFFAIRS Farnum Rhonda sold $218,167 worth of Ordinary Shares (13,314 units at $16.39) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 232,457 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TBPH· Theravance Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TBPH (Theravance Biopharma Inc.) and more on Quantisnow.